Keyphrases
Alveolar Epithelial Cells
25%
Calu-3
25%
Calu-3 Cells
25%
Camostat
25%
Cell Entry
25%
Chimeric Virus
25%
Coronavirus
25%
COVID-19
100%
COVID-19 Drugs
25%
COVID-19 Treatment
25%
Cytopathic Effect
25%
Drug Candidates
25%
Drug Discovery
25%
EC50
75%
Effective Concentration
25%
Efficacy Evaluation
25%
Epithelial Lung Cells
100%
Half Maximal Inhibitory Concentration
25%
Host Cell
25%
Host Cell Entry
25%
IC50
25%
Improved Activity
25%
In Vivo Efficacy
25%
Lung
25%
Lung Tissue
25%
Metabolic Stability
25%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
100%
Nafamostat
25%
Novel Class
100%
Pharmacokinetics
25%
Promising Drug
25%
Protease
25%
Rational Structure
25%
Recombinant
25%
Serine Protease
25%
Small Molecules
25%
Spike Protein
25%
Structure-based Drug Design
25%
Substrate Specificity
25%
Therapeutic Target
25%
TMPRSS2 Inhibitors
100%
TMPRSS2 Protein
25%
Transmembrane Protease Serine 2 (TMPRSS2)
50%
Viral Entry
100%
Viral Spread
25%
Virus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Camostat
25%
Drug Discovery
25%
EC50
100%
IC50
50%
Lead Compound
25%
Middle East Respiratory Syndrome Coronavirus
100%
Nafamstat
25%
Pharmacokinetics
25%
Proteinase
25%
Recombinant
25%
SARS Coronavirus
100%
Serine Proteinase
25%
Structure-Based Drug Design
25%
Substrate Specificity
25%
Vesiculovirus
25%